Assay		Ref.		Price ( $ )
GPCRs      Adenosine
			A1		G127	inquire
			A1 (agonist effect)		2814	inquire
			A1 (antagonist effect)		2820	inquire
			A1 (inverse agonist effect)		2408	inquire
			A2A		G002	inquire
			A2A (agonist effect)		2055	inquire
			A2A (antagonist effect)		2056	inquire
			A2A (agonist effect)-custom offer		2527	inquire
			A2A (inverse agonist effect)		2409	inquire
			A2B		G003	inquire
			A2B (agonist effect)		0452	inquire
			A2B (antagonist effect)		0455	inquire
			A3		G107	inquire
			A3 (agonist effect)		0982	inquire
			A3 (antagonist effect)		0983	inquire
GPCRs      Adrenergic
			alpha1A		G004	inquire
			alpha1A (agonist effect)		1500	inquire
			alpha1A (antagonist effect)		1501	inquire
			alpha1B		G005	inquire
			alpha1B (agonist effect)		1901	inquire
			alpha1B (antagonist effect)		1902	inquire
			alpha2A		G120	inquire
			alpha2A (agonist effect)		2558	inquire
			alpha2A (antagonist effect)		2559	inquire
			alpha2B		G011	inquire
			alpha2B (agonist effect)		1813	inquire
			alpha2B (antagonist effect)		1814	inquire
			alpha2C		G006	inquire
			alpha2C (agonist effect)		1736	inquire
			alpha2C (antagonist effect)		1737	inquire
			beta1		G007	inquire
			beta1 (agonist effect)		1605	inquire
			beta1 (antagonist effect)		1606	inquire
			beta1 (inverse agonist effect)		2377	inquire
			beta2		G008	inquire
			beta2 (agonist effect)		1976	inquire
			beta2 (antagonist effect)		1977	inquire
			beta2 (inverse agonist effect)		2407	inquire
			beta3		G009	inquire
			beta3 (agonist effect)		2189	inquire
			beta3 (antagonist effect)		2191	inquire
GPCRs      Angiotensin-II
			AT1		G052	inquire
			AT1 (agonist effect)		1912	inquire
			AT1 (antagonist effect)		1913	inquire
GPCRs      Apelin
			APJ (apelin)		G146	inquire
			APJ (apelin) (agonist effect)		2844	inquire
			APJ (apelin) (antagonist effect)		2850	inquire
GPCRs      Bombesin
			BB1		G147	inquire
			BB1 (agonist effect)		2846	inquire
			BB1 (antagonist effect)		2852	inquire
			BB2		G053	inquire
			BB2 (agonist effect)		1915	inquire
			BB2 (antagonist effect)		1916	inquire
			BB3		G054	inquire
			BB3 (agonist effect)		1319	inquire
			BB3 (antagonist effect)		1764	inquire
GPCRs      Bradykinin
			B1		G055	inquire
			B1 (agonist effect)		1108	inquire
			B1 (antagonist effect)		1109	inquire
			B2		G056	inquire
			B2 (agonist effect)		1263	inquire
			B2 (antagonist effect)		1743	inquire
GPCRs      Calcitonin
			CT (calcitonin)		G057	inquire
			CT (calcitonin) (agonist effect)		1964	inquire
			CT (calcitonin) (antagonist effect)		1965	inquire
GPCRs      Calcitonin gene-related peptide
			CGRP		G058	inquire
			CGRP (agonist effect)		1621	inquire
			CGRP (antagonist effect)		1622	inquire
GPCRs      Calcium sensing
			CaS		G010	inquire
			CaS (agonist effect)		2144	inquire
			CaS (antagonist effect)		2146	inquire
GPCRs      Cannabinoid
			CB1		G012	inquire
			CB1 (agonist effect)		1744	inquire
			CB1 (antagonist effect)		1745	inquire
			CB1 (inverse agonist effect)		2378	inquire
			CB2		G013	inquire
			CB2 (agonist effect)		1746	inquire
			CB2 (antagonist effect)		1747	inquire
			CB2 (inverse agonist effect)		2379	inquire
GPCRs      Chemokines
			CCR2		G138	inquire
			CCR2 (agonist effect)		2497	inquire
			CCR2 (antagonist effect)		2501	inquire
			CCR3		G148	inquire
			CCR3 (agonist effect)		2136	inquire
			CCR3 (antagonist effect)		2137	inquire
			CXCR2 (IL-8B)		G113	inquire
			CXCR2 (IL-8B) (agonist effect)		2480	inquire
			CXCR2 (IL-8B) (antagonist effect)		2482	inquire
			CXCR4		G114	inquire
			CXCR4 (agonist effect)		2464	inquire
			CXCR4 (antagonist effect)		2466	inquire
			CCR1		G168	inquire
			CCR1 (agonist effect)		2502	inquire
			CCR1 (antagonist effect)		2503	inquire
GPCRs      Cholecystokinin
			CCK1 (CCKA)		G062	inquire
			CCK1 (CCKA) (agonist effect)		1876	inquire
			CCK1 (CCKA) (antagonist effect)		1877	inquire
			CCK2 (CCKB)		G063	inquire
			CCK2 (CCKB) (agonist effect)		1878	inquire
			CCK2 (CCKB) (antagonist effect)		1879	inquire
GPCRs      Complement 5a
			C5a		G064	inquire
			C5a (agonist effect)		2089	inquire
			C5a (antagonist effect)		2098	inquire
GPCRs      Corticotropin releasing factor
			CRF1		G065	inquire
			CRF1 (agonist effect)		0504	inquire
			CRF1 (antagonist effect)		0505	inquire
			CRF2alpha		G066	inquire
			CRF2alpha (agonist effect)		2085	inquire
			CRF2alpha (antagonist effect)		2086	inquire
GPCRs      Dopamine
			D1		G014	inquire
			D1 (agonist effect)		1685	inquire
			D1 (antagonist effect)		1686	inquire
			D2S		G116	inquire
			D2S (agonist effect)		2566	inquire
			D2S (antagonist effect)		2569	inquire
			D3		G016	inquire
			D3 (agonist effect)		0683	inquire
			D3 (antagonist effect)		0684	inquire
			D4.4		G017	inquire
			D4.4 (agonist effect)		1699	inquire
			D4.4 (antagonist effect)		1700	inquire
			D5		G018	inquire
			D5 (agonist effect)		1688	inquire
			D5 (antagonist effect)		1689	inquire
GPCRs      Endothelin
			ETA		G067	inquire
			ETA (agonist effect)		1264	inquire
			ETA (antagonist effect)		2257	inquire
			ETB		G068	inquire
			ETB (agonist effect)		1762	inquire
			ETB (antagonist effect)		1763	inquire
GPCRs      Free fatty acid
			FFA1 (GPR40)		G123	inquire
			FFA1 (GPR40) (agonist effect)		2665	inquire
			FFA1 (GPR40) (antagonist effect)		2669	inquire
			FFA2 (GPR43)		G132	inquire
			FFA2 (GPR43) (agonist effect)		2710	inquire
			FFA2 (GPR43) (antagonist effect)		2714	inquire
			FFA3 (GPR41)		G143	inquire
			FFA3 (GPR41) (agonist effect)		2819	inquire
			FFA3 (GPR41) (antagonist effect)		2823	inquire
GPCRs      GABA
			GABAB		G111	inquire
			GABAB (agonist effect)		2525	inquire
			GABAB (antagonist effect)		2526	inquire
GPCRs      Galanin
			GAL2		G070	inquire
			GAL2 (agonist effect)		1292	inquire
			GAL2 (antagonist effect)		1893	inquire
GPCRs      Glucagon
			GLP-1		G072	inquire
			GLP-1 (agonist effect)		2181	inquire
			GLP-1 (antagonist effect)		2182	inquire
			secretin		G075	inquire
			secretin (agonist effect)		2012	inquire
			secretin (antagonist effect)		2014	inquire
			GLP-2		G073	inquire
			GLP-2 (agonist effect)		1993	inquire
			GLP-2 (antagonist effect)		1998	inquire
			glucagon		G074	inquire
			glucagon (agonist effect)		1839	inquire
			glucagon (antagonist effect)		1840	inquire
GPCRs      Glycoprotein hormone
			TSH		G076	inquire
			TSH (agonist effect)		2237	inquire
			TSH (antagonist effect)		2239	inquire
GPCRs      Growth hormone-releasing hormone
			GHRH		G071	inquire
			GHRH (agonist effect)		2236	inquire
			GHRH (antagonist effect)		2238	inquire
GPCRs      Histamine
			H1		G115	inquire
			H1 (agonist effect)		2542	inquire
			H1 (antagonist effect)		2543	inquire
			H2		G020	inquire
			H2 (agonist effect)		1695	inquire
			H2 (antagonist effect)		1696	inquire
			H2 (inverse agonist effect)		2380	inquire
			H3		G021	inquire
			H3 (agonist effect)		1800	inquire
			H3 (antagonist effect)		1801	inquire
			H4		G125	inquire
			H4 (agonist effect)		2595	inquire
			H4 (antagonist effect)		2599	inquire
GPCRs      Leukotrienes
			BLT1 (LTB4)		G023	inquire
			BLT1 (LTB4) (agonist effect)		1245	inquire
			BLT1 (LTB4) (antagonist effect)		1837	inquire
			CysLT1 (LTD4)		G024	inquire
			CysLT1 (LTD4) (agonist effect)		1383	inquire
			CysLT1 (LTD4) (antagonist effect)		1607	inquire
			CysLT2 (LTC4)		G025	inquire
			CysLT2 (LTC4) (agonist effect)		2051	inquire
			CysLT2 (LTC4) (antagonist effect)		2052	inquire
GPCRs      Lysophospholipid      Lysophosphatidic acid
			LPA2		G144	inquire
			LPA2 (agonist effect)		3171	inquire
			LPA2 (antagonist effect)		3172	inquire
			LPA3		G145	inquire
			LPA3 (agonist effect)		3158	inquire
			LPA3 (antagonist effect)		3170	inquire
GPCRs      Lysophospholipid      Sphingosine 1-phosphate
			S1P1		G205	inquire
			S1P1 (agonist effect)		3269	inquire
			S1P1 (antagonist effect)		3271	inquire
			S1P2		G026	inquire
			S1P2 (agonist effect)		2133	inquire
			S1P2 (antagonist effect)		2135	inquire
			S1P3		G027	inquire
			S1P3 (agonist effect)		2143	inquire
			S1P3 (antagonist effect)		2145	inquire
GPCRs      Melanin concentrating hormone
			MCH1		G077	inquire
			MCH1 (agonist effect)		1035	inquire
			MCH1 (antagonist effect)		1036	inquire
			MCH2		G078	inquire
			MCH2 (agonist effect)		1106	inquire
			MCH2 (antagonist effect)		1107	inquire
GPCRs      Melanocortin
			MC1		G079	inquire
			MC1 (agonist effect)		2147	inquire
			MC1 (antagonist effect)		2148	inquire
			MC2		G080	inquire
			MC2 (agonist effect)		2240	inquire
			MC2 (antagonist effect)		2241	inquire
			MC3		G081	inquire
			MC3 (agonist effect)		0959	inquire
			MC3 (antagonist effect)		1755	inquire
			MC4		G082	inquire
			MC4 (agonist effect)		0699	inquire
			MC4 (antagonist effect)		0700	inquire
			MC4 (inverse agonist effect)		2423	inquire
			MC5		G083	inquire
			MC5 (agonist effect)		1869	inquire
			MC5 (antagonist effect)		1870	inquire
GPCRs      Melatonin
			MT1 (ML1A)		G136	inquire
			MT1 (ML1A) (agonist effect)		2498	inquire
			MT1 (ML1A) (antagonist effect)		2500	inquire
			MT2 (ML1B)		G028	inquire
			MT2 (ML1B) (agonist effect)		2092	inquire
			MT2 (ML1B) (antagonist effect)		2100	inquire
GPCRs      Motilin
			motilin		G084	inquire
			motilin (agonist effect)		1321	inquire
			motilin (antagonist effect)		1894	inquire
GPCRs      Muscarinic
			M1		G029	inquire
			M1 (agonist effect)		1262	inquire
			M1 (antagonist effect)		1474	inquire
			M2		G030	inquire
			M2 (agonist effect)		1658	inquire
			M2 (antagonist effect)		1659	inquire
			M2 (inverse agonist effect)		2411	inquire
			M3		G031	inquire
			M3 (agonist effect)		1243	inquire
			M3 (antagonist effect)		1244	inquire
			M4		G032	inquire
			M4 (agonist effect)		1670	inquire
			M4 (antagonist effect)		1671	inquire
			M4 (inverse agonist effect)		2412	inquire
			M5		G033	inquire
			M5 (agonist effect)		1320	inquire
			M5 (antagonist effect)		1652	inquire
GPCRs      Neurokinin
			NK1		G085	inquire
			NK1 (agonist effect)		2190	inquire
			NK1 (antagonist effect)		2192	inquire
			NK2		G086	inquire
			NK2 (agonist effect)		1251	inquire
			NK2 (antagonist effect)		1765	inquire
			NK3		G087	inquire
			NK3 (agonist effect)		1312	inquire
			NK3 (antagonist effect)		1766	inquire
GPCRs      Neuromedin-U
			NMU1		G194	inquire
			NMU1 (agonist effect)		3310	inquire
			NMU1 (antagonist effect)		3312	inquire
GPCRs      Neuropeptide S
			NPS		G191	inquire
			NPS (agonist effect)		3291	inquire
			NPS (antagonist effect)		3292	inquire
GPCRs      Neuropeptide W / neuropeptide B
			NPBW1		G171	inquire
			NPBW1 (agonist effect)		2845	inquire
			NPBW1 (antagonist effect)		2851	inquire
GPCRs      Neuropeptide Y
			Y1		G088	inquire
			Y1 (agonist effect)		2206	inquire
			Y1 (antagonist effect)		2207	inquire
GPCRs      Neurotensin
			NTS1 (NT1)		G089	inquire
			NTS1 (NT1) (agonist effect)		1612	inquire
			NTS1 (NT1) (antagonist effect)		1634	inquire
			NTS2 (NT2)		G223	inquire
			NTS2 (NT2) (agonist effect)		1919	inquire
			NTS2 (antagonist effect)		1920	inquire
GPCRs      N-formyl peptide
			fMLP		G069	inquire
			fMLP (agonist effect)		2090	inquire
			fMLP (antagonist effect)		2097	inquire
GPCRs      Opioid and opioid-like
			delta2 (DOP)		G129	inquire
			delta2 (DOP) (agonist effect)		2568	inquire
			delta2 (DOP) (antagonist effect)		2571	inquire
			kappa (KOP)		G090	inquire
			kappa (KOP) (agonist effect)		2071	inquire
			kappa (KOP) (antagonist effect)		2072	inquire
			mu (MOP)		G091	inquire
			mu (MOP) (agonist effect)		1392	inquire
			mu (MOP) (antagonist effect)		1393	inquire
			NOP (ORL1)		G119	inquire
			NOP (ORL1) (agonist effect)		2381	inquire
			NOP (ORL1) (antagonist effect)		2382	inquire
GPCRs      Orexin
			OX1		G092	inquire
			OX1 (agonist effect)		2234	inquire
			OX1 (antagonist effect)		2235	inquire
			OX2		G093	inquire
			OX2 (agonist effect)		2349	inquire
			OX2 (antagonist effect)		2350	inquire
GPCRs      Orphans (Class A)
			GPR119		G189	inquire
			GPR119 (agonist effect)		3297	inquire
			GPR119 (antagonist effect)		3299	inquire
GPCRs      Parathyroid hormone
			PTH1		G130	inquire
			PTH1 (agonist effect)		2660	inquire
			PTH1 (antagonist effect)		2661	inquire
GPCRs      Platelet activating factor
			PAF		G034	inquire
			PAF (agonist effect)		1610	inquire
			PAF (antagonist effect)		1611	inquire
GPCRs      Prokineticin
			PK1		G117	inquire
			PK1 (agonist effect)		2449	inquire
			PK1 (antagonist effect)		2451	inquire
			PK2		G118	inquire
			PK2 (agonist effect)		2450	inquire
			PK2 (antagonist effect)		2452	inquire
GPCRs      Prostanoid
			IP		G039	inquire
			IP (agonist effect)		2228	inquire
			IP (antagonist effect)		2229	inquire
			DP1		G121	inquire
			DP1 (agonist effect)		2484	inquire
			DP1 (antagonist effect)		2486	inquire
			EP1		G035	inquire
			EP1 (agonist effect)		2053	inquire
			EP1 (antagonist effect)		2054	inquire
			EP2		G036	inquire
			EP2 (agonist effect)		1956	inquire
			EP2 (antagonist effect)		1957	inquire
			EP3		G122	inquire
			EP3 (agonist effect)		2577	inquire
			EP3 (antagonist effect)		2578	inquire
			EP4		G037	inquire
			EP4 (agonist effect)		1871	inquire
			EP4 (antagonist effect)		1872	inquire
			FP		G038	inquire
			FP (agonist effect)		2011	inquire
			FP (antagonist effect)		2013	inquire
			TP (TXA2/PGH2)		G040	inquire
			TP (TXA2/PGH2) (agonist effect)		2059	inquire
			TP (TXA2/PGH2) (antagonist effect)		2060	inquire
GPCRs      Proteinase-activated
			PAR1		G109	inquire
			PAR1 (agonist effect)		2332	inquire
			PAR1 (antagonist effect)		2333	inquire
			PAR2		G110	inquire
			PAR2 (agonist effect)		2323	inquire
			PAR2 (antagonist effect)		2324	inquire
GPCRs      Purinergic
			P2Y1		G041	inquire
			P2Y1 (agonist effect)		2132	inquire
			P2Y1 (antagonist effect)		2134	inquire
			P2Y2		G108